Viveon Health Acquisition... (VHAQ)
AMEX: VHAQ
· Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Jan 30, 2025, 9:00 PM
Viveon Health Acquisition Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | n/a | n/a | 77.86K | 19.85K | 286.09K | 1.46M | 2.08M | 395.24K | 575.25K | 1.06M | 1.45M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 203.28M | n/a | n/a |
Other Long-Term Assets | n/a | n/a | 20.34M | 53.82M | 52.82M | 51.87M | 51.56M | 203.28M | n/a | 203.27M | 203.27M |
Receivables | n/a | n/a | n/a | n/a | 15K | 15K | 15K | 15K | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | -49.08K | -58K | n/a | -18.86K | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | 5K | 48.73K | 49.08K | 58K | 15K | 18.86K | 196.14K | 339.67K | 514.17K |
Total Current Assets | n/a | n/a | 82.86K | 68.57K | 335.17K | 1.52M | 2.09M | 414.1K | 771.39K | 1.4M | 1.96M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | 20.48M | 53.85M | 52.82M | 51.87M | 51.56M | 203.28M | 203.28M | 203.27M | 203.27M |
Total Assets | n/a | n/a | 20.56M | 53.92M | 53.15M | 53.39M | 53.66M | 203.7M | 204.05M | 204.67M | 205.23M |
Account Payables | n/a | n/a | 223.57K | 226.8K | 209.32K | 160.57K | 235.28K | 47.72K | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 4.51M | 4.08M | 1.1M | 359.29K | 99.54K | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | 3.1M | 34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | n/a | n/a | 7.84M | 40.91M | 4.49M | 3.28M | 3.21M | 2.19M | 355.33K | 191.57K | 109.15K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 9.68M | 14.27M | 13.33M | 14.15M | 11.23M | 11.72M | 13.68M | 13.91M |
Total Long-Term Liabilities | n/a | n/a | 9.14M | 9.68M | 14.27M | 13.33M | 14.15M | 11.23M | 11.72M | 13.68M | 13.91M |
Total Liabilities | n/a | n/a | 7.84M | 50.59M | 18.76M | 16.61M | 17.36M | 13.42M | 12.07M | 13.87M | 14.02M |
Total Debt | n/a | n/a | 4.51M | 4.08M | 1.1M | 359.29K | 99.54K | n/a | n/a | n/a | n/a |
Common Stock | n/a | n/a | 503.00 | 19.41M | 52.51M | 51.77M | 50.83M | 203.26M | 203.26M | 185.8M | 186.21M |
Retained Earnings | n/a | n/a | -15.94M | -16.08M | -18.12M | -15M | -14.69M | -13.14M | -11.29M | 1.36M | 1.77M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | n/a | n/a | -15.94M | 3.33M | 34.39M | 36.78M | 36.3M | 190.28M | 191.98M | 190.8M | 191.21M |
Total Investments | n/a | n/a | n/a | 53.82M | 52.82M | 51.87M | 51.56M | 203.28M | 203.28M | 203.27M | 203.27M |